CANF
Can-Fite BioPharma
CANF
CANF
7 hedge funds and large institutions have $2.26M invested in Can-Fite BioPharma in 2016 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 3 closing their positions.
Holders
7
Holders Change
-2
Holders Change %
-22.22%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TAM
1
Taylor Asset Management
Toronto,
Ontario, Canada
|
$2.11M |
| 2 |
AG
2
Advisor Group
Phoenix,
Arizona
|
$10K |
Top Sellers
| 1 |
VKH
1
Virtu KCG Holdings
New York
|
$0 |
| 2 |
ARTA
2
A.R.T. Advisors
New York
|
$0 |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$1K |
| 4 |
IA
4
IFP Advisors
Tampa,
Florida
|
$3K |
| 5 |
PCM
5
Prelude Capital Management
New York
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TAM
1
Taylor Asset Management
Toronto,
Ontario, Canada
| $2.11M | 796,500 | +166,000 | +26% |
|
|
MC
2
Menta Capital
San Francisco,
California
| $115K | 43,832 | -1,657 | -4% |
|
3
Morgan Stanley
New York
| $14K | 5,400 | -170 | -3% |
|
|
AG
4
Advisor Group
Phoenix,
Arizona
| $10K | 4,000 | +4,000 | New |
|
5
Group One Trading
Chicago,
Illinois
| $5K | 2,048 | – | – |
|
|
IA
6
IFP Advisors
Tampa,
Florida
| $3K | 1,000 | -7,900 | -89% |
|
|
7
UBS Group
Zurich,
Switzerland
| $1K | 204 | -5,876 | -97% |
|
|
VKH
8
Virtu KCG Holdings
New York
| – | – | -27,573 | Closed |
|
|
ARTA
9
A.R.T. Advisors
New York
| – | – | -16,238 | Closed |
|
|
PCM
10
Prelude Capital Management
New York
| – | – | -2,800 | Closed |
|